30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Tharimmune Inc (THAR)

Track

Over the last 90 days, Tharimmune Inc. has seen 8 insider transactions, all of which were sell orders totaling $343,882.44. Notably, Gary S. Stetz executed multiple sell transactions in late May 2026. There were no insider buy transactions recorded in this period. The stock has experienced an 18.3% price decrease over the past 90 days.
Stock chart
Ticker: THAR Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Stetz Gary S.
1 sale — total 43,375 USD
Sale 26 May 2026
Value US$883,175.62 | Price 497.90 | Shares 99,065
Sale 22 May 2026
Value US$3,441,440.66 | Price 342.35 | Shares 43,469
Sale 22 May 2026
Value US$2,336,138.35 | Price 450.00 | Shares 99,394
Sale 22 May 2026
Value US$51,150.00 | Price 3.41 | Shares 15,000
Sale 22 May 2026
Value US$51,150.00 | Price 3.41 | Shares 15,000
Sale 22 May 2026
Value US$51,000.00 | Price 3.40 | Shares 15,000
Sale 22 May 2026
Value US$34,500.00 | Price 3.45 | Shares 10,000
Sale 22 May 2026
Value US$34,500.00 | Price 3.45 | Shares 10,000
Buy 20 Jun 2025
Value US$500,000.24 | Price 1.48 | Shares 337,838
Buy 20 Jun 2025
Value US$1,450.00 | Price 1.45 | Shares 1,000
Buy 20 Jun 2025
Value US$979.80 | Price 1.42 | Shares 690
Buy 20 Jun 2025
Value US$89,992.88 | Price 1.48 | Shares 60,806
Buy 15 May 2025
Value US$1,001.00 | Price 1.30 | Shares 770
Buy 19 Dec 2024
Value US$9,752.00 | Price 2.12 | Shares 4,600
Buy 13 Nov 2024
Value US$10,096.00 | Price 2.02 | Shares 5,000
Buy 8 Oct 2024
Value US$743.40 | Price 2.10 | Shares 354
Buy 8 Oct 2024
Value US$1,350.14 | Price 2.09 | Shares 646
Buy 8 Oct 2024
Value US$3,127.50 | Price 2.09 | Shares 1,500
Buy 8 Oct 2024
Value US$9,650.00 | Price 1.93 | Shares 5,000
Buy 15 Dec 2023
Value US$14,587.00 | Price 0.50 | Shares 29,000
Buy 30 Nov 2023
Value US$10,000.00 | Price 1.00 | Shares 10,000
Buy 17 Jun 2022
Value US$389.95 | Price 0.78 | Shares 500
Buy 6 Jun 2022
Value US$349.95 | Price 0.70 | Shares 500
Buy 6 Jun 2022
Value US$44.23 | Price 0.67 | Shares 66
Buy 6 Jun 2022
Value US$67.01 | Price 0.67 | Shares 100
Buy 6 Jun 2022
Value US$67.01 | Price 0.67 | Shares 100
Buy 6 Jun 2022
Value US$160.27 | Price 0.68 | Shares 234
Buy 1 Jun 2022
Value US$0.94 | Price 0.94 | Shares 1
Buy 25 May 2022
Value US$632.00 | Price 0.79 | Shares 800
Buy 25 May 2022
Value US$154.00 | Price 0.77 | Shares 200
Buy 20 May 2022
Value US$473.25 | Price 0.95 | Shares 500
Buy 20 May 2022
Value US$445.00 | Price 0.89 | Shares 500
Buy 19 May 2022
Value US$450.00 | Price 0.90 | Shares 500
Buy 19 May 2022
Value US$457.65 | Price 0.92 | Shares 500
Buy 14 Jan 2022
Value US$100,000.00 | Price 4.00 | Shares 25,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-27 2026-05-26 S Sale
Stetz Gary S.
Non-Executive Director
99,065 +43.4%
497.90
US$883,176 		99,065 +43.4% 497.90 US$883,176
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
43,469 +34.0%
342.35
US$3,441,441 		43,469 +34.0% 342.35 US$3,441,441
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
99,394 -40.2%
450.00
US$2,336,138 		99,394 -40.2% 450.00 US$2,336,138
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
15,000 -8.1%
3.41
US$51,150 		15,000 -8.1% 3.41 US$51,150
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
15,000 -7.5%
3.41
US$51,150 		15,000 -7.5% 3.41 US$51,150
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
15,000 -7.0%
3.40
US$51,000 		15,000 -7.0% 3.40 US$51,000
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
10,000 -4.5%
3.45
US$34,500 		10,000 -4.5% 3.45 US$34,500
2026-05-27 2026-05-22 S Sale
Stetz Gary S.
Non-Executive Director
10,000 -4.3%
3.45
US$34,500 		10,000 -4.3% 3.45 US$34,500
2025-06-23 2025-06-20 B Purchase
3.3
Gravitas Capital LP

Executive Chairman

Executive Director Large shareholder
337,838 +85.6%
1.48
US$500,000 		337,838 +85.6% 1.48 US$500,000
2025-06-23 2025-06-20 B Purchase
3.7
Parikh Sanam
Non-Executive Director
1,000 +129.9%
1.45
US$1,450 		1,000 +129.9% 1.45 US$1,450
2025-06-23 2025-06-20 B Purchase
4.0
Appajosyula Sireesh

Chief Executive Officer

Executive Director
690 +1.1%
1.42
US$980 		690 +1.1% 1.42 US$980
2025-06-23 2025-06-20 B Purchase
4.0
Appajosyula Sireesh

Chief Executive Officer

Executive Director
60,806 +1803.3%
1.48
US$89,993 		60,806 +1803.3% 1.48 US$89,993
2025-05-16 2025-05-15 B Purchase
3.7
Parikh Sanam
Non-Executive Director
770 +inf%
1.30
US$1,001 		770 +inf% 1.30 US$1,001
2024-12-20 2024-12-19 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
4,600 +35.6%
2.12
US$9,752 		4,600 +35.6% 2.12 US$9,752
2024-11-13 2024-11-13 B Purchase
4.0
Appajosyula Sireesh

Chief Operating Officer

Executive Director
5,000 +86.8%
2.02
US$10,096 		5,000 +86.8% 2.02 US$10,096
2024-10-10 2024-10-08 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
354 +2.8%
2.10
US$743 		354 +2.8% 2.10 US$743
2024-10-10 2024-10-08 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
646 +5.4%
2.09
US$1,350 		646 +5.4% 2.09 US$1,350
2024-10-10 2024-10-08 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
1,500 +14.4%
2.09
US$3,128 		1,500 +14.4% 2.09 US$3,128
2024-10-08 2024-10-08 B Purchase
4.0
Appajosyula Sireesh

Chief Operating Officer

Executive Director
5,000 +44.0%
1.93
US$9,650 		5,000 +44.0% 1.93 US$9,650
2023-12-18 2023-12-15 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
29,000 +22.7%
0.50
US$14,587 		29,000 +22.7% 0.50 US$14,587
2023-12-04 2023-11-30 B Purchase
2.1
MILBY RANDY

CEO

Executive Director
10,000 +8.5%
1.00
US$10,000 		10,000 +8.5% 1.00 US$10,000
2022-06-21 2022-06-17 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director Large shareholder
500 +0.0%
0.78
US$390 		500 +0.0% 0.78 US$390
2022-06-07 2022-06-06 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
500 +0.0%
0.70
US$350 		500 +0.0% 0.70 US$350
2022-06-07 2022-06-06 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
66 +0.0%
0.67
US$44 		66 +0.0% 0.67 US$44
2022-06-07 2022-06-06 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
100 +0.0%
0.67
US$67 		100 +0.0% 0.67 US$67
2022-06-07 2022-06-06 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
100 +0.0%
0.67
US$67 		100 +0.0% 0.67 US$67
2022-06-07 2022-06-06 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
234 +0.0%
0.68
US$160 		234 +0.0% 0.68 US$160
2022-06-02 2022-06-01 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
1
0.94
US$1 		1 0.94 US$1
2022-05-25 2022-05-25 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
800 +0.0%
0.79
US$632 		800 +0.0% 0.79 US$632
2022-05-25 2022-05-25 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
200 +0.0%
0.77
US$154 		200 +0.0% 0.77 US$154
2022-05-23 2022-05-20 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
500 +0.0%
0.95
US$473 		500 +0.0% 0.95 US$473
2022-05-23 2022-05-20 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
500 +0.0%
0.89
US$445 		500 +0.0% 0.89 US$445
2022-05-19 2022-05-19 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
500 +0.0%
0.90
US$450 		500 +0.0% 0.90 US$450
2022-05-19 2022-05-19 B Purchase
2.1
MILBY RANDY

Chief Executive Officer

Executive Director
500 +0.0%
0.92
US$458 		500 +0.0% 0.92 US$458
2022-01-18 2022-01-14 B Purchase
Mazur Leonard L
Non-Executive Director
25,000 +25.3%
4.00
US$100,000 		25,000 +25.3% 4.00 US$100,000
Explore more

More insider trading research around Tharimmune Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America